Showing results (1791-1800 of 1,912) with videos related to

Sort By:
Pageof 192
Science Advances|December 4, 2024
A trafficking regulatory subnetwork governs α<sub>V</sub>β<sub>6</sub> integrin-HER2 cross-talk to control breast cancer invasion and drug resistanceHoracio Maldonado, Marcel Dreger, Lara D Bedgood, et al.
Digestive Diseases and Sciences|December 11, 2024
Access to Evaluation for Liver Transplantation in the Veterans Health AdministrationVera Yakovchenko, Michael F Chang, Ruben Hernaez, et al.
Proceedings. Biological Sciences|July 24, 2024
Improve animal health to reduce livestock emissions: quantifying an open goalIlias Kyriazakis, Claudia Arndt, Aurelie Aubry, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Annals of Internal Medicine|June 1, 1997
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trialJ P Cello, E J Ring, E W Olcott, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Plos One|May 27, 2026
Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trialMandy H M Chu, Jacky K M Lai, Anna Lee, et al.
Gastroenterology|December 7, 2010
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CAnna S Lok, James E Everhart, Elizabeth C Wright, et al.
The New England Journal of Medicine|December 5, 2008
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie, Mitchell L Shiffman, Gregory T Everson, et al.
Pageof 192